ClinicalTrials.Veeva

Menu

Oxytocin Effects on Food Motivation Pathways

Mass General Brigham logo

Mass General Brigham

Status and phase

Completed
Early Phase 1

Conditions

Overweight and Obesity

Treatments

Drug: Placebo
Drug: Oxytocin

Study type

Interventional

Funder types

Other

Identifiers

NCT02276677
SPID 1127

Details and patient eligibility

About

Oxytocin is a peptide hormone produced in the brain that regulates food intake. However, the mechanisms for this effect in humans is not yet clear.

In this study, the investigators will therefore examine the effect of a single dose of intranasal oxytocin (compared to placebo) on levels of appetite-regulating hormones and functional magnetic resonance imaging activation of areas of the brain involved in food motivation.

Enrollment

10 patients

Sex

Male

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age 18-45 years old
  • BMI 25-40
  • Regular breakfast eater (at least 4 times per week)
  • Stable weight within the past three months

Exclusion criteria

  • Psychiatric disease, use of psychotropic medications
  • History of eating disorder
  • History of excessive exercise within the last three months (having run more that 25 miles in any one week or having exercised more than ten hours in any one week)
  • History of diabetes mellitus
  • Active substance abuse
  • Hematocrit lower than the normal range
  • Gastrointestinal tract surgery (including gastrectomy, gastric bypass surgery, and small or large bowel resection)
  • History of cardiovascular disease (such as hypertrophic cardiomyopathy, valvular heart disease, coronary heart disease, or coronary artery spasms)
  • Untreated thyroid disease
  • Tobacco use
  • Cardiac pacemaker, surgical aneurysm clips, neurostimulator, implanted pumps, metal fragments in body/eyes, nitroglycerin patch, severe claustrophobia

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Triple Blind

10 participants in 2 patient groups, including a placebo group

Oxytocin
Experimental group
Description:
Oxytocin 24 IU x 1
Treatment:
Drug: Oxytocin
Placebo
Placebo Comparator group
Description:
Placebo 24 IU x 1
Treatment:
Drug: Placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems